Prolonged Exposure to Loteprednol Etabonate in Human Tear Fluid and Rabbit Ocular Tissues Following Topical Ocular Administration of Lotemax Gel, 0.5%-Reference-Cited by-同舟云学术

Prolonged Exposure to Loteprednol Etabonate in Human Tear Fluid and Rabbit Ocular Tissues Following Topical Ocular Administration of Lotemax Gel, 0.5%

Published:2014-02 Issue:1 Volume:30 Page:66-73
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Glogowski Shellise¹,Lowe Ezra¹,Siou-Mermet Raphaele²,Ong Tuyen³,Richardson Mary⁴

Affiliation:

1. Drug Metabolism and Pharmacokinetics, Global Pharmaceutical R&D, Bausch & Lomb, Inc., Rochester, New York.

2. European Pharmaceutical Clinical Science, Bausch & Lomb, Inc., Evry cedex, France.

3. Clinical Development, Global Pharmaceuticals, Bausch & Lomb, Inc., Madison, New Jersey.

4. Preclinical Development, Global Pharmaceutical R&D, Bausch & Lomb, Inc., Rochester, New York.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2013.0142

Reference44 articles.

1. Minimizing systemic absorption of topically administered ophthalmic drugs

2. Ocular Drug Delivery

3. Barriers to Glaucoma Drug Delivery

4. Safety Evaluation of Ocular Drug Delivery Formulations: Techniques and Practical Considerations

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dry Eye Disease: Focus on Prescription Therapy;The Senior Care Pharmacist;2023-06-01

2. Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery;Trends in Molecular Medicine;2021-05

3. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives;Drug Delivery and Translational Research;2020-09-08

4. Loteprednol Etabonate for the Treatment of Dry Eye Disease;Journal of Ocular Pharmacology and Therapeutics;2020-09-01

5. Rheological Properties, Dissolution Kinetics, and Ocular Pharmacokinetics of Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%;Journal of Ocular Pharmacology and Therapeutics;2019-06